Liver resection for hepatocellular carcinoma in non-cirrhotic liver without underlying viral hepatitis

被引:94
作者
Lang, H
Sotiropoulos, GC
Dömland, M
Frühauf, NR
Paul, A
Hüsing, J
Malagó, M
Broelsch, CE
机构
[1] Univ Essen Gesamthsch, Klinikum Essen, Klin Allgemein & Transplantationschirurg, D-45122 Essen, Germany
[2] Univ Hosp Essen, Klin Allgemein & Transplantationschirurg, Essen, Germany
[3] Univ Essen Gesamthsch, Inst Med Informat Biometrie & Epidemiol, Essen, Germany
关键词
D O I
10.1002/bjs.4763
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Hepatocellular carcinoma (HCC arising in normal liver parenchyma is rare and the outcome after hcpatectomy is not well documented. Methods: Between June 1998 and September 2003, 33 patients without viral hepatitis underwent resection for HCC in a non-cirrhotic, non-fibrotic liver. Data were analysed with regard to operative details, pathological findings including completeness of resection, and outcome as measured by tumour recurrence and survival. Results: Twenty-three major hepatectomies and ten segmentectomies or bisegmentectomies were performed. After potentially curative resection, 19 of 29 patients were alive at a median follow-up of 25 months, with calculated 1- and 3-year survival rates of 87 and 50 per cent respectively. Survival was significantly better after resection of tumours without vascular invasion (3-year survival rate 89 versus 18 per cent; P = 0.024). Disseminated recurrence developed in nine of 29 patients, leading to death within 28 months of operation in all but one of the nine. Conclusion: These data justify hepatic resection for HCC arising in non-cirrhotic, non-fibrotic liver without underlying viral hepatitis. Liver transplantation is rarely indicated because the outcome is good after resection of tumours without vascular infiltration, whereas vascular invasion is invariably associated with diffuse extrahepatic recurrence.
引用
收藏
页码:198 / 202
页数:5
相关论文
共 37 条
[1]  
[Anonymous], 2000, HPB, DOI DOI 10.1080/136518202760378489
[2]   SURGICAL-TREATMENT OF HEPATOCELLULAR CARCINOMAS IN NONCIRRHOTIC LIVER - EXPERIENCE WITH 68 LIVER RESECTIONS [J].
BISMUTH, H ;
CHICHE, L ;
CASTAING, D .
WORLD JOURNAL OF SURGERY, 1995, 19 (01) :35-41
[3]   Predictors and patterns of recurrence after resection of hepatocellular carcinoma [J].
Cha, C ;
Fong, YM ;
Jarnagin, WR ;
Blumgart, LH ;
DeMatteo, RP .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2003, 197 (05) :753-758
[4]   Hepatocellular carcinoma: Multimodality management [J].
Christians, KK ;
Pitt, HA ;
Rilling, WS ;
Franco, J ;
Quiroz, FA ;
Adams, MB ;
Wallace, JR ;
Quebbeman, EJ .
SURGERY, 2001, 130 (04) :554-559
[5]   Carcinogenesis of primary liver malignancies [J].
Dürr, R ;
Caselmann, WH .
LANGENBECKS ARCHIVES OF SURGERY, 2000, 385 (03) :154-161
[6]   Hepatectomy for hepatocellular carcinoma: Toward zero hospital deaths [J].
Fan, ST ;
Lo, CM ;
Liu, CL ;
Lam, CM ;
Yuen, WK ;
Yeung, C ;
Wong, J .
ANNALS OF SURGERY, 1999, 229 (03) :322-330
[7]   CURRENT TREATMENT MODALITIES FOR HEPATOCELLULAR-CARCINOMA [J].
FARMER, DG ;
ROSOVE, MH ;
SHAKED, A ;
BUSUTTIL, RW .
ANNALS OF SURGERY, 1994, 219 (03) :236-247
[8]   Subcutaneous seeding of hepatocellular carcinoma after fine-needle percutaneous biopsy [J].
Fiore, F ;
Daniele, B ;
De Maio, E ;
Tambaro, R ;
Iaffaioli, VR ;
Barbarisi, A ;
Pignata, S .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2001, 33 (02) :171-171
[9]   An analysis of 412 cases of hepatocellular carcinoma at a western center [J].
Fong, YM ;
Sun, RL ;
Jarnagin, W ;
Blumgart, LH .
ANNALS OF SURGERY, 1999, 229 (06) :790-799
[10]   Prognosis of a large cohort of patients with hepatocellular carcinoma in a single European centre [J].
Herold, C ;
Reck, T ;
Fischler, P ;
Ott, R ;
Radespiel-Troeger, M ;
Ganslmayer, M ;
Hohenberger, W ;
Hahn, EG ;
Schuppan, D .
LIVER, 2002, 22 (01) :23-28